Middle East & Africa Anterior Uveitis Treatment Market Size & Outlook
Related Markets
MEA anterior uveitis treatment market highlights
- The MEA anterior uveitis treatment market generated a revenue of USD 7.8 million in 2022.
- The market is expected to grow at a CAGR of 9.9% from 2023 to 2030.
- In terms of segment, non-infectious uveitis was the largest revenue generating type in 2022.
- Non-Infectious Uveitis is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, South Africa is expected to register the highest CAGR from 2023 to 2030.
MEA data book summary
| Market revenue in 2022 | USD 7.8 million |
| Market revenue in 2030 | USD 16.6 million |
| Growth rate | 9.9% (CAGR from 2022 to 2030) |
| Largest segment | Non-infectious uveitis |
| Fastest growing segment | Non-Infectious Uveitis |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Infectious Uveitis, Non-Infectious Uveitis |
| Key market players worldwide | Novartis AG ADR, Santen Pharmaceutical Co Ltd, AbbVie Inc, Kiora Pharmaceuticals Inc, Clearside Biomedical Inc, Aldeyra Therapeutics Inc, UCB SA, Aciont, Sirion Therapeutics, Lux Biosciences |
Other key industry trends
- In terms of revenue, MEA region accounted for 1.9% of the global anterior uveitis treatment market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 485.9 million by 2030.
Key Regions: U.S. , UK , Japan , Brazil , South Africa
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anterior Uveitis Treatment Market Scope
Anterior Uveitis Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lux Biosciences | View profile | 11-50 | Jersey City, New Jersey, United States, North America | http://www.luxbio.com |
| Sirion Therapeutics | View profile | 101-250 | Tampa, Florida, United States, North America | https://www.siriontherapeutics.com/ |
| Aciont | View profile | 1-10 | Salt Lake City, Utah, United States, North America | https://www.aciont.com/ |
| Aldeyra Therapeutics Inc | View profile | 10 | 131 Hartwell Avenue, Suite 320, Lexington, MA, United States, 02421 | https://www.aldeyra.com |
| Clearside Biomedical Inc | View profile | 30 | 900 North Point Parkway, Suite 200, Alpharetta, GA, United States, 30005 | https://www.clearsidebio.com |
| Kiora Pharmaceuticals Inc | View profile | 12 | 332 Encinitas Boulevard, Suite 102, Encinitas, CA, United States, 92024 | https://www.kiorapharma.com |
| Santen Pharmaceutical Co Ltd | View profile | 1807 | Grand Front Osaka Tower A, 4-20 Ofuka-cho, Kita-ku, Osaka, Japan, 530-8552 | http://www.santen.co.jp |
| UCB SA | View profile | 9083 | Allee de la Recherche, 60, Brussels, Belgium, B-1070 | https://www.ucb.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Middle East & Africa anterior uveitis treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anterior uveitis treatment market will help companies and investors design strategic landscapes.
Non-infectious uveitis was the largest segment with a revenue share of 53.85% in 2022. Horizon Databook has segmented the Middle East & Africa anterior uveitis treatment market based on infectious uveitis, non-infectious uveitis covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Middle East & Africa anterior uveitis treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa anterior uveitis treatment market databook
-
Our clientele includes a mix of anterior uveitis treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa anterior uveitis treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa anterior uveitis treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA anterior uveitis treatment market size, by country, 2018-2030 (US$M)
Middle East & Africa Anterior Uveitis Treatment Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
